6 [18] N. Jana, K. Vasishta, S. K. Jindal et al., “Perinatal outcome in pregnancies complicated by pulmonary tuberculosis,” Interna- tional Journal of Gynecology and Obstetrics, vol. 44, no. 2, pp. 119–124, 1994. [19] M. Cantwell, D. E. Snider Jr., G. M. Cauthen, and I. M. Onorato, “Epidemiology of tuberculosis in the United States, 1985 through 1992,” JAMA, vol. 272, no. 7, pp. 535–539, 1994. [20] J. R. Starke, “Tuberculosis: an old disease but a new threat to the mother, fetus, and neonate,” Clinics in Perinatology, vol. 24, no. 1, pp. 107–127, 1997. [21] M. A. Hamadeh and J. Glassroth, “Tuberculosis and preg- nancy,” Chest, vol. 101, no. 4, pp. 1114–1120, 1992. [22] M. R. Cantwell, Z. M. Shehab, A. M. Costello et al., “Brief report: congenital tuberculosis,” New England Journal of Med- icine, vol. 330, no. 15, pp. 1051–1054, 1994. [23] R. Nemir and D. O’Hare, “Congenital tuberculosis,” American Journal of Diseases of Children, vol. 139, no. 3, pp. 284–287, 1985. [24] B. L. Varudkar, “Short course chemotherapy for tuberculosis in children,” The Indian Journal of Pediatrics, vol. 52, no. 419, pp. 593–597, 1985. [25] Medical Research Council Tuberculosis and Chest Disease Unit, “Management and outcome of chemotherapy for child- hood tuberculosis,” Archives of Disease in Childhood, vol. 64, no. 7, pp. 1004–1012, 1989. [26] J. Biddulph, “Short course chemotherapy for childhood tuber- culosis,” Pediatric Infectious Disease Journal, vol. 9, no. 11, pp. 793–801, 1990. [27] R. F. C. Doveren and R. Block, “Tuberculosis and pregnan- cy: a provincial study (1990-1996),” Netherlands Journal of Medicine, vol. 52, no. 3, pp. 100–106, 1998. [28] J. T. Good, M. D. Iseman, and P. T. Davidson, “Tuberculosis in association with pregnancy,” American Journal of Obstetrics and Gynecology, vol. 140, no. 5, pp. 492–498, 1981. [29] E. J. Carter and S. Mates, “Tuberculosis during pregnancy: the Rhode Island experience, 1987 to 1991,” Chest, vol. 106, no. 5, pp. 1466–1470, 1994. [30] M. T. Medchill and M. Gillum, “Diagnosis and management of tuberculosis during pregnancy,” Obstetrical and Gynecological Survey, vol. 44, no. 2, pp. 81–84, 1989. [31] R. Finn, C. A. St Hill, A. Govan, I. G. Ralfs, F. J. Gurney, and V. Denye, “Immunological responses in pregnancy and survival of fetal homograft,” British medical journal, vol. 3, no. 819, pp. 150–152, 1972. [32] P. Present and G. W. Comstock, “Tuberculin sensitivity in pregnancy,” American Review of Respiratory Disease, vol. 112, no. 3, pp. 413–416, 1975. [33] N. L. Eriksen and A. W. Helfgott, “Cutaneous anergy in pregnant and non-pregnant women with human immunode- ﬁciency virus,” Infectious Diseases in Obstetrics and Gynecology, vol. 6, pp. 13–17, 1998. [34] L. M. Mofenson, E. M. Rodriguez, R. Hershow et al., “Myco- bacterium tuberculosis infection in pregnant and nonpreg- nant women infected with HIV in the women and infants transmission study,” Archives of Internal Medicine, vol. 155, no. 10, pp. 1066–1071, 1995. [35] T. E. Nolan, T. L. Espinosa, and J. G. Pastorek, “Tuberculosis skin testing in pregnancy: trends in a population,” Journal of Perinatology, vol. 17, no. 3, pp. 199–201, 1997. [36] J. B. Bass Jr., L. S. Farer, P. C. Hopewell et al., “Treatment of tuberculosis and tuberculosis infection in adults and children,” American Journal of Respiratory and Critical Care Medicine, vol. 149, no. 5, pp. 1359–1374, 1994. Journal of Pregnancy [37] The Global Plan to Stop Tb 2011-2015: Transforming the Fight Towards Elimination of Tuberculosis, World Health Organiza- tion, Geneva, Switzerland, 2010. [38] Pathways to Better Diagnostics for Tuberculosis; A Blueprint for Development of TB Diagnostics, World Health Organization, Geneva, Switzerland, 2009. [39] Centre for Disease Control, “Treatment of tuberculosis,” MMWR, vol. 52, no. RR-11, pp. 1–77, 2003. [40] Joint Tuberculosis Committee of the British Thoracic Soci- ety, “Chemotherapy and management of tuberculosis: recom- mendations 1998,” Thorax, vol. 53, pp. 536–548, 1998. [41] Singapore Tuberculosis Service and British Medical Research Council, “Clinical trial of six-month and four-month chem- otherapy in the treatment of pulmonary tuberculosis. The results up to 30 months ,” Tubercle, vol. 62, pp. 95–102, 1981. [42] East and Central African and British Medical Research Coun- cil, “Clinical controlled trial of four short course regimens of chemotherapy (three six-months and one eight months) for pulmonary tuberculosis,” Tubercle, vol. 64, pp. 153–166, 1983. [43] British Thoracic Society, “A controlled trial of 6 month’s chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and be- yond,” British Journal of Diseases of the Chest, vol. 78, no. 4, pp. 330–336, 1984. [44] L. P. Ormerod, “Chemotherapy of tuberculosis,” European Re- spiratory Monograph, vol. 2, supplement 4, pp. 273–297, 1997. [45] J. H. Tran and P. Montakantikul, “The safety of antitubercu- losis medications during breastfeeding,” Journal of Human Lactation, vol. 14, no. 4, pp. 337–340, 1998. [46] G. Bothamley, “Drug treatment for tuberculosis during preg- nancy: safety considerations,” Drug Safety, vol. 24, no. 7, pp. 553–565, 2001. [47] T. Lewitt, L. Nebel, S. Terracina, and S. Karman, “Ethambutol in pregnancy: observations on embryogenesis,” Chest, vol. 66, no. 1, pp. 25–26, 1974. [48] G. D. Anderson, “Tuberculosis in pregnancy,” Seminars in Per- inatology, vol. 21, no. 4, pp. 328–335, 1997. [49] Management, Control and Prevention of Tuberculosis; Guide- lines for Health Care Providers (2002–2005), Department of Human Services, Victoria, Australia, 2002. [50] H. M. Blumberg, W. J. Burman, R. E. Chaisson et al., “American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 4, pp. 603–662, 2003. [51] Anon, “Treatment of tuberculosis,” MMWR Recommendations and Reports, vol. 52, pp. 1–77, 2003. [52] J. G. Bartlett, “Guidelines section,” Infectious Diseases in Clini- cal Practice, vol. 11, pp. 467–471, 2002. [53] D. Heilman, F. Heilman, H. Hinshaw et al., “Streptomycin: absorption, diﬀusion, excretion and toxicity,” The American Journal of the Medical Sciences, vol. 210, pp. 576–584, 1945. [54] J. Woltz and M. Wiley, “Transmission of streptomycin from maternal blood to the fetal circulation and amniotic ﬂuid,” Proceedings of the Society for Experimental Biology and Medi- cine, vol. 60, pp. 106–107, 1945. [55] J. T. Good, M. D. Iseman, and P. T. Davidson, “Tuberculosis in association with pregnancy,” American Journal of Obstetrics and Gynecology, vol. 140, no. 5, pp. 492–498, 1981. [56] I. Khan and A. Azam, “Study of teratogenic activity of tri- ﬂuoperazine,amitriptyline, ethionamide and thalidomide in pregnant rabbits and mice,” Proceedings of the European Society for the Study of Drug Toxicity, vol. 10, pp. 235–242, 1969.